HIV treatment with tenofovir alafenamide fumarate (TAF) has decreased renal toxicity compared with tenofovir disoproxil fumarate in clinical trials. We report the case of a patient with HIV/HCV coinfection who was started on a TAF-based HIV regimen and developed acute kidney injury that worsened with the addition of sofosbuvir-ledipasvir.
CITATION STYLE
Serota, D. P., Franch, H. A., & Cartwright, E. J. (2018). Acute kidney injury in a patient on tenofovir alafenamide fumarate after initiation of treatment for hepatitis C virus infection. Open Forum Infectious Diseases, 5(8). https://doi.org/10.1093/ofid/ofy189
Mendeley helps you to discover research relevant for your work.